53 related articles for article (PubMed ID: 34106817)
1. Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6.
Serag Eldien MM; Abdou AG; Elghrabawy GRA; Alhanafy AM; Mahmoud SF
J Immunoassay Immunochem; 2021 Nov; 42(6):662-678. PubMed ID: 34106817
[TBL] [Abstract][Full Text] [Related]
2. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.
Sikic D; Keck B; Wach S; Taubert H; Wullich B; Goebell PJ; Kahlmeyer A; Olbert P; Isfort P; Nimphius W; Hartmann A; Giedl J;
PLoS One; 2017; 12(6):e0179602. PubMed ID: 28632777
[TBL] [Abstract][Full Text] [Related]
4. A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing.
Angeloni M; van Doeveren T; Lindner S; Volland P; Schmelmer J; Foersch S; Matek C; Stoehr R; Geppert CI; Heers H; Wach S; Taubert H; Sikic D; Wullich B; van Leenders GJ; Zaburdaev V; Eckstein M; Hartmann A; Boormans JL; Ferrazzi F; Bahlinger V
J Pathol Clin Res; 2024 Mar; 10(2):e12369. PubMed ID: 38504364
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder.
Elsayed AM; Mahmoud EI; Salem MM; Khairy RA
Asian Pac J Cancer Prev; 2024 Feb; 25(2):637-646. PubMed ID: 38415551
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma.
Yang Y; Li J; Yao W; Zou G; Ye X; Mo Q
BMC Urol; 2024 Apr; 24(1):88. PubMed ID: 38627689
[TBL] [Abstract][Full Text] [Related]
7. The urothelial gene regulatory network: understanding biology to improve bladder cancer management.
Ramal M; Corral S; Kalisz M; Lapi E; Real FX
Oncogene; 2024 Jan; 43(1):1-21. PubMed ID: 37996699
[TBL] [Abstract][Full Text] [Related]
8. TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma.
Brunelli M; Gobbo S; Malpeli G; Sirgiovanni G; Caserta C; Munari E; Francesconi S; Caliò A; Martignoni G; Cimadamore A; Veccia A; Antonelli A; Tucci M; Pierconti F; Hattab IM; Eccher A; Ascani S; Milella M; Buffoni L; Cheng L; Bracarda S
Pathologica; 2024 Feb; 116(1):55-61. PubMed ID: 38482675
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes-Preliminary Report.
Sanguedolce F; Falagario UG; Zanelli M; Palicelli A; Zizzo M; Ascani S; Tortorella S; Busetto GM; Cormio A; Carrieri G; Cormio L
Curr Issues Mol Biol; 2024 Mar; 46(3):2456-2467. PubMed ID: 38534771
[TBL] [Abstract][Full Text] [Related]
10. GATA3 Expression in Prostatic Adenosquamous Carcinoma: A Potential Diagnostic Pitfall.
Potterveld SK; Williamson SR; Al-Obaidy KI; Akgul M; Chan E; Giannico GA; Sangoi AR
Int J Surg Pathol; 2024 Apr; ():10668969241241640. PubMed ID: 38562047
[TBL] [Abstract][Full Text] [Related]
11. Relationship between tumor thickness and GATA3 immunoexpression in lip and tongue squamous cell carcinomas.
Vital AGB; de Carvalho MCM; Maia CR; Galvão HC; de Souza LB; de Andrade Santos PP
Oral Maxillofac Surg; 2024 Apr; ():. PubMed ID: 38600414
[TBL] [Abstract][Full Text] [Related]
12. GATA3 Positively Correlates with BCL2 Expression in Indolent and Aggressive Histological Types of Cutaneous Basal Cell Carcinoma.
Elkhamisy FAA; Eesa AN; Sallam MK; Hussein MF; Abd-El-Moeze NA
Turk Patoloji Derg; 2024 Apr; ():. PubMed ID: 38668712
[TBL] [Abstract][Full Text] [Related]
13. Bladder Cancer: New Insights into Its Molecular Pathology.
Inamura K
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29614760
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9802197. PubMed ID: 38550132
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant Histology.
de Jong JJ; Narayan VM; Cronican AA; Gupta S; van Leenders GJLH; Boormans JL; Gibb EA; Konety BR
Am J Clin Pathol; 2021 Oct; 156(5):895-905. PubMed ID: 34157072
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in
Chu CE; Sjöström M; Egusa EA; Gibb EA; Badura ML; Zhu J; Koshkin VS; Stohr BA; Meng MV; Pruthi RS; Friedlander TW; Lotan Y; Black PC; Porten SP; Feng FY; Chou J
Clin Cancer Res; 2021 Sep; 27(18):5123-5130. PubMed ID: 34108177
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma.
Choi JH; Thung SN
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672619
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer.
Sanguedolce F; Falagario UG; Zanelli M; Palicelli A; Zizzo M; Ascani S; Tortorella S; Mancini V; Cormio A; Carrieri G; Cormio L
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047581
[TBL] [Abstract][Full Text] [Related]
19. Integrated Analysis of the Fecal Metagenome and Metabolome in Bladder Cancer in a Chinese Population.
Qin C; Chen Z; Cao R; Shi M; Tian Y
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360204
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
